Lucy Liaw

The University of Maine, United States 
Cell Biology, Biochemistry, Molecular Biology, Oncology
"Lucy Liaw"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gurumurthy CB, O'Brien AR, Quadros RM, et al. (2019) Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation. Genome Biology. 20: 171
Scott SS, Yang X, Robich M, et al. (2019) Differentiation Capacity of Human Aortic Perivascular Adipose Progenitor Cells. Journal of Visualized Experiments : Jove
Su S, Guntur AR, Nguyen DC, et al. (2018) A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome. Cell Reports. 25: 3215-3228.e9
Boucher JM, Robich M, Scott SS, et al. (2018) Rab27a Regulates Human Perivascular Adipose Progenitor Cell Differentiation. Cardiovascular Drugs and Therapy
Peterson SM, Turner JE, Harrington A, et al. (2018) Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation. Arteriosclerosis, Thrombosis, and Vascular Biology
Davis-Knowlton J, Turner JE, Turner A, et al. (2018) Characterization of smooth muscle cells from human atherosclerotic lesions and their responses to Notch signaling. Laboratory Investigation; a Journal of Technical Methods and Pathology
Fairfield H, Falank C, Farrell M, et al. (2018) Development of a 3D bone marrow adipose tissue model. Bone
Yang X, Gong Y, He Q, et al. (2017) Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. Journal of Cellular Biochemistry
Jing H, Liaw L, Friesel R, et al. (2017) Erratum to: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell International. 17: 53
He Q, Jing H, Liaw L, et al. (2017) Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype. Scientific Reports. 7: 46791
See more...